Literature DB >> 973810

Progressive rubella panencephalitis.

J S Wolinsky, B O Berg, C H Maitalnd.   

Abstract

A patient with progressive rubella panencephalitis developed initial symptoms of neurologic deterioration 12 years after childhood German measles. Progressive rubella panencephalitis should be considered in adolescents with progressive dementia attended by pyradmidal and cerebellar dysfunction.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 973810     DOI： 10.1001/archneur.1976.00500100056016

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


  8 in total

1.  Neurology-epitomes of progress: progressive rubella panencephalitis.

Authors:  B O Berg
Journal:  West J Med       Date:  1977-08

2.  Preventing the congenital rubella syndrome by vaccinating women at risk.

Authors:  J H Joncas
Journal:  Can Med Assoc J       Date:  1983-07-15       Impact factor: 8.262

3.  Neurological complications following rubella infection.

Authors:  M Bechar; S Davidovich; G Goldhammer; I Machtey; N Gadoth
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

4.  Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody.

Authors:  M J Buchmeier; H A Lewicki; P J Talbot; R L Knobler
Journal:  Virology       Date:  1984-01-30       Impact factor: 3.616

Review 5.  Subacute sclerosing panencephalitis.

Authors:  Ravindra Kumar Garg
Journal:  J Neurol       Date:  2008-10-14       Impact factor: 4.849

6.  Immunochemical features of a case of progressive rubella panencephalitis.

Authors:  J S Wolinsky; M N Waxham; J L Hess; J J Townsend; J R Baringer
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

7.  Virus-specific and autoreactive T cell lines isolated from cerebrospinal fluid of a patient with chronic rubella panencephalitis.

Authors:  R Martin; P Marquardt; S O'Shea; M Borkenstein; H W Kreth
Journal:  J Neuroimmunol       Date:  1989-06       Impact factor: 3.478

Review 8.  Mechanisms and consequences of virus persistence in the human nervous system.

Authors:  V ter Meulen; M J Carter; H Wege; R Watanabe
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.